What is the appropriate workup, including laboratory studies, for a patient with an intrauterine device (IUD) presenting with vaginal bleeding?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Workup for Vaginal Bleeding in IUD Users

The essential workup for vaginal bleeding in an IUD user must first rule out pregnancy (including ectopic pregnancy), followed by assessment for infection (STDs/PID), IUD displacement, and structural uterine pathology—with specific laboratory studies and imaging guided by clinical presentation and risk factors.

Initial Critical Assessment

Immediate Laboratory Studies

Pregnancy testing is mandatory as the first step in any IUD user with vaginal bleeding 1. This is non-negotiable because:

  • Ectopic pregnancy risk is elevated with IUD failure
  • Septic abortion can be life-threatening if pregnancy occurs with IUD in situ
  • Management fundamentally changes if pregnancy is present

Complete blood count (CBC) should be obtained to:

  • Assess for anemia from blood loss
  • Evaluate for infection if clinically indicated 2

Risk-Stratified Laboratory Evaluation

For women over age 40 or with risk factors for endometrial pathology, additional workup includes:

  • Endometrial sampling is indicated, as 13.8% of IUD users over 40 with abnormal bleeding have endometrial hyperplasia 3
  • This is particularly important with >5 years of IUD use

If infection is suspected (fever, pain, abnormal discharge):

  • STD testing (gonorrhea, chlamydia)
  • Consider inflammatory markers if PID is suspected 1

Clinical Examination Requirements

Speculum Examination Must Assess:

  • IUD string visibility - critical for determining next steps 1
  • Cervical appearance and discharge
  • Active bleeding source
  • Signs of infection or trauma

Pelvic Examination Should Evaluate:

  • Uterine size, tenderness, masses
  • Adnexal tenderness or masses
  • Cervical motion tenderness (suggests PID)

Imaging Algorithm

Transvaginal ultrasound is the primary imaging modality and should be performed when 4:

  • IUD strings are not visible (to locate device and rule out perforation) 1
  • Structural pathology is suspected (fibroids, polyps, adenomyosis)
  • Endometrial thickness needs assessment in postmenopausal women
  • Pregnancy cannot be definitively ruled out

Saline-infusion sonohysterography or hysteroscopy may be needed if:

  • Initial ultrasound is inconclusive
  • Endometrial pathology is suspected but not clearly visualized 5

Type-Specific Considerations

For Copper IUD Users:

  • Heavy bleeding is common in first 3-6 months and generally benign 1
  • Persistent heavy bleeding beyond 6 months warrants full workup for structural pathology
  • Chronic endometritis is more common with >5 years use 3

For LNG-IUD Users:

  • Heavy or prolonged bleeding is uncommon and should prompt immediate investigation 1
  • Consider IUD displacement, pregnancy, STD, or new pathologic conditions (polyps, fibroids) 1
  • Abrupt change from regular pattern to amenorrhea warrants pregnancy testing 1

Critical Pitfalls to Avoid

Do not assume the IUD "fell out" without confirmation - it may have perforated the uterus or migrated 1, 6. Always perform ultrasound if strings are not visible.

Do not delay endometrial sampling in high-risk patients (age >40, obesity, history of anovulation, >5 years IUD use) even if ultrasound appears normal 3.

Do not attribute all bleeding to the IUD - maintain high suspicion for pregnancy complications, infection, and malignancy based on patient age and risk factors 2, 5.

The guideline evidence [1-1] consistently emphasizes that while bleeding irregularities are common with IUDs, clinically indicated workup should always consider underlying gynecological problems rather than assuming bleeding is device-related, particularly when patterns are atypical for the IUD type or timing of use.

References

Research

Evaluation of patients with abnormal uterine bleeding.

American journal of obstetrics and gynecology, 1996

Research

Should endometrial hyperplasia be regarded as a reason for abnormal uterine bleeding in users of the intrauterine contraceptive device?

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 2003

Guideline

acr appropriateness criteria® abnormal uterine bleeding.

Journal of the American College of Radiology, 2020

Research

Abnormal uterine bleeding.

American family physician, 2004

Research

The case of the migrating IUD.

The Practitioner, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.